DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapidcardiomyopathyheart failuregeneticsventricular arrhythmiaCMR

Dilated cardiomyopathy

Essential points for quick revision.

!
Escalate

Syncope with ventricular arrhythmia, cardiogenic shock, pulmonary oedema or rapidly progressive conduction disease requires urgent monitored admission and senior cardiology input.

Synopsis

Recognise the DCM phenotype, find reversible and inherited causes, treat heart failure and prevent arrhythmic death.

  • DCM is LV or biventricular dilatation with systolic dysfunction not explained solely by abnormal loading or coronary disease.
  • A normal coronary angiogram identifies non-ischaemic dysfunction; it does not establish an idiopathic diagnosis.
  • Ask specifically about family sudden death, alcohol, pregnancy, myocarditis, chemotherapy, toxins and neuromuscular features.

Key red flags

High-risk course

Unexplained syncope, sustained VT, extensive scar, severe biventricular failure or progressive conduction block signals risk beyond symptoms or LVEF alone.

Investigation priorities

01
12-lead ECG and ambulatory rhythm monitoringFirst step

Detect AF, conduction disease and ventricular arrhythmia.

Management branches

AcuteDecompensation or shock

Pulmonary oedema, hypoperfusion or serious arrhythmia.

  1. Assess ABCDE, continuous ECG, oxygen only if hypoxaemic, IV access, renal/electrolytes, troponin/NT-proBNP and urgent bedside echo.
  2. Treat congestion with IV loop diuretic; if shock persists, escalate immediately to critical care and an advanced-heart-failure centre for inotrope or mechanical-support assessment.
ChronicHFrEF and arrhythmic protection

Stable DCM after congestion is controlled.

Key medicines

Dapagliflozin10 mg orally once daily for chronic HFrEF.
SpironolactoneUsually 25 mg orally once daily; reduce or titrate according to renal function, potassium and response.
Open full textbook Answer 2 questionsCardiology check
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom